| Ident. | Authors (with country if any) | Title |
|---|
| 000650 |
A. Palache [Pays-Bas] ; A. Abelin [France] ; R. Hollingsworth [France] ; W. Cracknell [Australie] ; C. Jacobs [Belgique] ; T. Tsai [États-Unis] ; P. Barbosa [Suisse] | Survey of distribution of seasonal influenza vaccine doses in 201 countries (2004-2015): The 2003 World Health Assembly resolution on seasonal influenza vaccination coverage and the 2009 influenza pandemic have had very little impact on improving influenza control and pandemic preparedness. |
| 000910 |
Kaatje Bollaerts [Belgique] ; Vivek Shinde [États-Unis] ; Gaël Dos Santos [Belgique] ; Germano Ferreira [Belgique] ; Vincent Bauchau [Belgique] ; Catherine Cohet [Belgique] ; Thomas Verstraeten [Belgique] | Application of Probabilistic Multiple-Bias Analyses to a Cohort- and a Case-Control Study on the Association between Pandemrix™and Narcolepsy |
| 000937 |
J. Finsterer [Autriche, Allemagne] ; W. N. Löscher [Autriche] ; J. Wanschitz [Autriche] ; S. Quasthoff [Autriche] ; W. Grisold [Autriche] | Secondary myopathy due to systemic diseases |
| 000E47 |
Christine Hohenadl [Autriche] ; Walter Wodal [Autriche] ; Astrid Kerschbaum [Autriche] ; Richard Fritz [Autriche] ; M Keith Howard [Autriche] ; Maria R. Farcet [Autriche] ; Daniel Portsmouth [Autriche] ; John K. Mcvey [États-Unis] ; Donald A. Baker [États-Unis] ; Hartmut J. Ehrlich [Autriche] ; P Noel Barrett [Autriche] ; Thomas R. Kreil [Autriche] | Hyperimmune intravenous immunoglobulin containing high titers of pandemic H1N1 hemagglutinin and neuraminidase antibodies provides dose-dependent protection against lethal virus challenge in SCID mice |
| 000F03 |
Alex B. Ryder [États-Unis] ; Linda Buonocore [États-Unis] ; Leatrice Vogel [États-Unis] ; Raffael Nachbagauer [États-Unis, Autriche] ; Florian Krammer [États-Unis] ; John K. Rose [États-Unis] | A Viable Recombinant Rhabdovirus Lacking Its Glycoprotein Gene and Expressing Influenza Virus Hemagglutinin and Neuraminidase Is a Potent Influenza Vaccine |
| 000F69 |
Monika Redlberger-Fritz [Autriche] ; Sonja Hirk [Autriche] ; Dieter Buchinger [Autriche] ; Renate Haberl [Autriche] ; Markus Hell [Autriche] ; Nicole Perkmann-Nagele [Autriche] ; Michael Kundi [Autriche] ; Therese Popow-Kraupp [Autriche] | Distinct differences in clinical manifestation and viral laboratory parameters between children and adults with influenza A(H1N1)pdm09 infection—A retrospective comparative analysis |
| 001011 |
Michael Pfleiderer [Allemagne] ; Jean-Hugues Trouvin [France] ; Daniel Brasseur [Belgique] ; Marta Gr Nstrom [Suède] ; Ragini Shivji [Royaume-Uni] ; Manuela Mura [Royaume-Uni] ; Marco Cavaleri [Royaume-Uni] | Summary of knowledge gaps related to quality and efficacy of current influenza vaccines |
| 001031 |
Cornelia Lackner [Autriche] ; Sandra M. Leydold [Autriche] ; Jens Modrof [Autriche] ; Maria R. Farcet [Autriche] ; Leopold Grillberger [Autriche] ; Birgit Sch Fer [Autriche] ; Heinz Anderle [Autriche] ; Thomas R. Kreil [Autriche] | Reduction of spiked porcine circovirus during the manufacture of a Vero cell-derived vaccine |
| 001053 |
Miriam Klausberger [Autriche] ; Monika Wilde [Autriche] ; Dieter Palmberger [Autriche] ; RONG HAI [États-Unis] ; Randy A. Albrecht [États-Unis] ; Irina Margine [États-Unis] ; Ariana Hirsh [États-Unis] ; Adolfo Garcia-Sastre [États-Unis] ; Reingard Grabherr [Autriche] ; Florian Krammer [États-Unis] | One-shot vaccination with an insect cell-derived low-dose influenza A H7 virus-like particle preparation protects mice against H7N9 challenge |
| 001071 |
A. Morokutti [Autriche] ; T. Muster [Autriche] ; B. Ferko [Autriche] | Intranasal vaccination with a replication-deficient influenza virus induces heterosubtypic neutralising mucosal IgA antibodies in humans |
| 001463 |
Daniele De Luca [Italie, France] ; Marco Piastra [Italie] ; Giovanna Chidini [Italie] ; Pierre Tissieres [France] ; Edoardo Calderini [Italie] ; Sandrine Essouri [France] ; Alberto Medina Villanueva [Espagne] ; Ana Vivanco Allende [Espagne] ; Marti Pons-Odena [Espagne] ; Luis Perez-Baena [Espagne] ; Michael Hermon [Autriche] ; Ascanio Tridente [Royaume-Uni] ; Giorgio Conti [Italie] ; Massimo Antonelli [Italie] ; Martin Kneyber [Pays-Bas] | The use of the Berlin definition for acute respiratory distress syndrome during infancy and early childhood: multicenter evaluation and expert consensus |
| 001743 |
P. Noel Barrett [Autriche] ; Daniel Portsmouth [Autriche] ; Hartmut J. Ehrlich [Autriche] | Vero cell culture-derived pandemic influenza vaccines: preclinical and clinical development |
| 001A13 |
Eva Kowalinski [France] ; Chloe Zubieta [France] ; Andrea Wolkerstorfer [Autriche] ; Oliver H. J. Szolar [Autriche] ; Rob W. H. Ruigrok [France] ; Stephen Cusack [France] | Structural Analysis of Specific Metal Chelating Inhibitor Binding to the Endonuclease Domain of Influenza pH1N1 (2009) Polymerase |
| 001B02 |
Heimo Lagler [Autriche] ; Katharina Grabmeier-Pfistershammer [Autriche] ; Veronique Touzeau-Römer [Autriche] ; Selma Tobudic [Autriche] ; Michael Ramharter [Autriche, Allemagne] ; Judith Wenisch [Autriche] ; Guido Andrés Gualdoni [Autriche] ; Monika Redlberger-Fritz [Autriche] ; Theresia Popow-Kraupp [Autriche] ; Armin Rieger [Autriche] ; Heinz Burgmann [Autriche] | Immunogenicity and Tolerability after Two Doses of Non-Adjuvanted, Whole-Virion Pandemic Influenza A (H1N1) Vaccine in HIV-Infected Individuals |
| 001E14 |
Monika Redlberger-Fritz [Autriche] ; Judith Helene Aberle [Autriche] ; Therese Popow-Kraupp [Autriche] ; Michael Kundi [Autriche] | Attributable deaths due to influenza: a comparative study of seasonal and pandemic influenza |
| 001E68 |
A. Hombrouck [Belgique] ; M. Sabbe [Belgique] ; V. Van Casteren [Belgique] ; F. Wuillaume [Belgique] ; D. Hue [Belgique] ; M. Reynders [Belgique] ; C. Gerard [Belgique] ; B. Brochier [Belgique] ; J. Van Eldere [Belgique] ; M. Van Ranst [Belgique] ; I. Thomas [Belgique] | Viral aetiology of influenza-like illness in Belgium during the influenza A(H1N1)2009 pandemic |
| 001F47 |
M. Redlberger-Fritz [Autriche] ; S. W. Aberle [Autriche] ; R. Strassl [Autriche] ; T. Popow-Kraupp [Autriche] | Rapid identification of neuraminidase inhibitor resistance mutations in seasonal influenza virus A(H1N1), A(H1N1)2009, and A(H3N2) subtypes by melting point analysis |
| 002232 |
Richard Fritz [Viêt Nam] ; Nicolas Sabarth [Viêt Nam] ; Stefan Kiermayr [Viêt Nam] ; Christine Hohenadl [Viêt Nam] ; M. Keith Howard [Viêt Nam] ; Reinhard Ilk [Viêt Nam] ; Otfried Kistner [Viêt Nam] ; Hartmut J. Ehrlich [Autriche] ; P. Noel Barrett [Viêt Nam] ; Thomas R. Kreil [Viêt Nam] | A Vero Cell-Derived Whole-Virus H5N1 Vaccine Effectively Induces Neuraminidase-Inhibiting Antibodies |
| 002812 |
Hung-Wei Kuo [Autriche] ; Daniela Schmid [Autriche] ; Yu-Lun Liu [Autriche] ; Peter Lachner [Autriche] ; Franz Allerberger [Autriche] | Influenza-related excess mortality, Austria 2001 till 2009 |
| 002892 |
W. Poeppl [Autriche] ; M. Hell [Autriche] ; H. Herkner [Autriche] ; B. Stoiser [Autriche] ; G. Fritsche [Autriche] ; N. Schurz-Bamieh [Autriche] ; G. Poeppl [Autriche] ; R. Gattringer [Autriche] ; N. Jones [Autriche] ; M. Maass [Autriche] ; A. Egle [Autriche] ; H. Burgmann [Autriche] | Clinical aspects of 2009 pandemic influenza A (H1N1) virus infection in Austria |
| 002937 |
Peter Schellongowski [Autriche] ; Roman Ullrich [Autriche] ; Cornelia Hieber [Autriche] ; Hubert Hetz [Autriche] ; Heidrun Losert [Autriche] ; Maria Hermann [Autriche] ; Alexander Hermann [Autriche] ; Klaus-Bernhard Gattringer [Autriche] ; Viktoria Siersch [Autriche] ; Werner Rabitsch [Autriche] ; Valentin Fuhrmann [Autriche] ; Andja Bojic [Autriche] ; Oliver Robak [Autriche] ; Wolfgang R. Sperr [Autriche] ; Klaus Laczika [Autriche] ; Gottfried J. Locker [Autriche] ; Thomas Staudinger [Autriche] | A surge of flu-associated adult respiratory distress syndrome in an Austrian tertiary care hospital during the 2009/2010 Influenza A H1N1v pandemic |
| 002A25 |
Konstantin H. Müller [Luxembourg (pays)] ; Denis E. Kainov [Luxembourg (pays)] ; Karim El Bakkouri [Belgique] ; Xavier Saelens [Belgique] ; Jef K. De Brabander [États-Unis] ; Christian Kittel [Autriche] ; Elisabeth Samm [Autriche] ; Claude P. Muller [Luxembourg (pays)] | The proton translocation domain of cellular vacuolar ATPase provides a target for the treatment of influenza A virus infections |
| 002B39 |
Fernanda Tavares [Belgique] ; Irwin Nazareth [Royaume-Uni] ; Javier Sawchik Monegal [Belgique] ; Ida Kolte [Belgique] ; Thomas Verstraeten [Belgique] ; Vincent Bauchau [Belgique] | Pregnancy and safety outcomes in women vaccinated with an AS03-adjuvanted split virion H1 N1 (2009) pandemic influenza vaccine during pregnancy: A prospective cohort study |
| 002B65 |
Heimo Lagler [Autriche] ; Judith M. Wenisch [Autriche] ; Selma Tobudic [Autriche] ; Guido A. Gualdoni [Autriche] ; Susanne Rödler [Autriche] ; Susanne Rasoul-Rockenschaub [Autriche] ; Peter Jaksch [Autriche] ; Monika Redlberger-Fritz [Autriche] ; Theresia Popow-Kraupp [Autriche] ; Heinz Burgmann [Autriche] | Pandemic influenza A H1N1 vaccine in recipients of solid organ transplants: Immunogenicity and tolerability outcomes after vero cell derived, non-adjuvanted, whole-virion vaccination |
| 002C36 |
Atika Abelin [Suisse] ; Tony Colegate [Suisse] ; Stephen Gardner [Belgique] ; Norbert Hehme [Suisse] ; Abraham Palache [Suisse] | Lessons from pandemic influenza A(H1 N1 ): The research-based vaccine industry's perspective |
| 002F11 |
Marina De Filette [Belgique] ; Tine Ysenbaert [Belgique] ; Kenny Roose [Belgique] ; Michael Schotsaert [Belgique] ; Stefan Roels [Belgique] ; Els Goossens [Belgique] ; Bert Schepens [Belgique] ; Walter Fiers [Belgique] ; Xavier Saelens [Belgique] | Antiserum against the conserved nine amino acid N-terminal peptide of influenza A virus matrix protein 2 is not immunoprotective |
| 003697 |
Florian Krammer [Autriche] ; Theresa Schinko [Autriche] ; Dieter Palmberger [Autriche] ; Christopher Tauer [Autriche] ; Paul Messner [Autriche] ; Reingard Grabherr [Autriche] | Trichoplusia ni cells (High Five) are highly efficient for the production of influenza A virus-like particles: a comparison of two insect cell lines as production platforms for influenza vaccines |
| 003940 |
François Roman [Belgique] ; Tejaswini Vaman [Belgique] ; Beatrice Gerlach [Allemagne] ; Andre Markendorf [Allemagne] ; Paul Gillard [Belgique] ; Jeanne-Marie Devaster [Belgique] | Immunogenicity and safety in adults of one dose of influenza A H1N1v 2009 vaccine formulated with and without AS03A-adjuvant: Preliminary report of an observer-blind, randomised trial |
| 003A86 |
Roman Chlibek [République tchèque] ; Ioana Anca [Roumanie] ; Francis Andre [Belgique] ; Mustafa Bakir [Turquie] ; Inga Ivaskeviciene [Lituanie] ; Atanas Mangarov [Bulgarie] ; Zs Fia Meszner [Hongrie] ; Penka Perenovska [Bulgarie] ; Roman Prymula [République tchèque] ; Darko Richter [Croatie] ; Nuran Salman [Turquie] ; Pavol Simurka [Slovaquie] ; Eda Tamm [Estonie] ; Nataša Toplak [Slovénie] ; Vytautas Usonis [Lituanie] | Central European Vaccination Advisory Group (CEVAG) guidance statement on recommendations for 2009 pandemic influenza A(H1N1) vaccination |
| 003D50 |
F. M. Fusco [Italie] ; V. Puro [Italie] ; A. Baka [Grèce] ; B. Bannister [Royaume-Uni] ; H.-R. Brodt [Allemagne] ; P. Brouqui [France] ; P. Follin [Suède] ; I. E. Gjorup [Danemark] ; R. Gottschalk [Allemagne] ; R. Hemmer [Luxembourg (pays)] ; I. M. Hoepelman [Pays-Bas] ; B. Jarhall [Suède] ; K. Kutsar [Estonie] ; S. Lanini [Italie] ; O. Lyytikainen [Finlande] ; H. C. Maltezou [Grèce] ; K. Mansinho [Portugal] ; M. C. Marti [Espagne] ; K. Ott [Estonie] ; R. Peleman [Belgique] ; C. Perronne [France] ; G. Sheehan [Irlande (pays)] ; H. Siikamakii [Finlande] ; P. Skinhoj [Danemark] ; A. Trilla [Espagne] ; N. Vetter [Autriche] ; G. Ippolito [Italie] | Isolation rooms for highly infectious diseases: an inventory of capabilities in European countries |
| 004136 |
Kurt A. Jellinger [Autriche] | Absence of α-synuclein pathology in postencephalitic parkinsonism |
| 004661 |
Karin Levie [Belgique] ; Isabel Leroux-Roels [Belgique] ; Karel Hoppenbrouwers [Belgique] ; Anne-Diane Kervyn [Belgique] ; Corinne Vandermeulen [Belgique] ; Sheron Forgus [Belgique] ; Geert Leroux-Roels [Belgique] ; Sylvie Pichon [France] ; Inca Kusters [France] | An Adjuvanted, Low-Dose, Pandemic Influenza A (H5N1) Vaccine Candidate Is Safe, Immunogenic, and Induces Cross-Reactive Immune Responses in Healthy Adults |
| 004691 |
Dirk Proske [Autriche, Allemagne] | Risks and Disasters |
| 004700 |
Juergen Mairhofer [Autriche] ; Reingard Grabherr [Autriche] | Rational Vector Design for Efficient Non-viral Gene Delivery: Challenges Facing the Use of Plasmid DNA |
| 004862 |
Patrick Goubau [Belgique] | LES MALADIES VIRALES ÉMERGENTES EN BELGIQUE ET AILLEURS |
| 004875 |
Karin Riedl [Autriche] ; Rosemarie Riedl [Autriche] ; Alexander Von Gabain [Autriche] ; Eszter Nagy [Autriche] ; Karen Lingnau [Autriche] | The novel adjuvant IC31® strongly improves influenza vaccine-specific cellular and humoral immune responses in young adult and aged mice |
| 004917 |
Thierry Van Den Berg [Belgique] ; Bénédicte Lambrecht [Belgique] ; Sylvie Marche [Belgique] ; Mieke Steensels [Belgique] ; Steven Van Borm [Belgique] ; Michel Bublot [France] | Influenza vaccines and vaccination strategies in birds |
| 004C21 |
Landis Mackellar [Autriche] | Pandemic Influenza: A Review |
| 004C58 |
Ursula Kunze [Autriche] ; Ernest Groman [Autriche] ; Gabriela Böhm [Autriche] ; Michael Kunze [Autriche] | Influenza vaccination in Austria, 1982–2003 |
| 004C82 |
T. R. Kreil [Autriche] ; U. Unger [Autriche] ; S. M. Orth [Autriche] ; G. Petutschnig [Autriche] ; O. Kistner [Autriche] ; G. Poelsler [Autriche] ; A. Berting [Autriche] | H5N1 influenza virus and the safety of plasma products |
| 005112 |
Julia Romanova [Autriche] | The fight against new types of influenza virus |
| 005358 |
Kenneth Strauss [Belgique] ; André Van Zundert [Pays-Bas] ; Anders Frid [Suède] ; Vincenzo Costigliola [Belgique] | Pandemic influenza preparedness : The critical role of the syringe |
| 005D03 |
Adolfo Garc Amp X0301 A-Sastre ; Andrej Egorov [Autriche] ; Demetrius Matassov ; Sabine Brandt [Autriche] ; David E. Levy ; Joan E. Durbin ; Peter Palese ; Thomas Muster [Autriche] | Influenza A Virus Lacking the NS1 Gene Replicates in Interferon-Deficient Systems |
| 005D38 |
G. K. Wenning [États-Unis] ; K. Jellinger [Autriche] ; I. Litvan [États-Unis] | Supranuclear gaze palsy and eyelid apraxia in postencephalitic parkinsonism |
| 005D51 |
R. Snacken [Belgique] | Influenza : le risque pandémique |
| 006197 |
M. Just [Suisse] ; A. Bürgin-Wolff [Suisse] ; R. Berger-Hernandez [Suisse] ; A. B Chlin [Suisse] ; G. Ritzel [Suisse] ; A. J. Moritz [Autriche] | A/New Jersey/76 influenza vaccine trial in seronegative schoolchildren: Comparison of a subunit vaccine with a whole-virus vaccine |
